SCHEMBL19690532

SCHEMBL19690532

COC(=O)C1(C(=O)OC)C(c2ccccc2)=C(c2ccccc2C(F)(F)F)c2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ FFAR4 Q5NUL3 1/20 0.37
▸ HPGD P15428 2/20 0.36
▸ KMO O15229 1/20 0.36
▸ STK10 O94804 1/20 0.36
▸ SLK Q9H2G2 1/20 0.36
▸ PDK2 Q15119 5/20 0.36
▸ HSD11B1 P28845 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ FFAR1 O14842 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ PPARG P37231 1/20 0.35
▸ PPARA Q07869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18663292 0.84 BACE1 (0.43) MAPTFFAR4PDK2FFAR1
SCHEMBL18663293 0.80 SLC6A3 (0.45) ALDH1A1LMNAPOLBMAPTSLK
SCHEMBL19690698 0.80 GAA (0.38) LMNAPOLBGAASMN1; SMN2TDP1
SCHEMBL18663367 0.79 FGFR1 (0.39) ALDH1A1LMNAPOLBSMN1; SMN2MAPT
SCHEMBL18663404 0.77 MAPT (0.46) ALDH1A1LMNASMN1; SMN2MAPTHPGD
SCHEMBL18663374 0.76 OPRK1 (0.39) ALDH1A1LMNAPOLBGAAMAPT
SCHEMBL18663305 0.73 OPRK1 (0.37) ALDH1A1LMNAPOLBGAAMAPT
SCHEMBL18663359 0.70 ALDH1A1 (0.43) ALDH1A1LMNAGAASMN1; SMN2MAPT
SCHEMBL18663375 0.70 ALDH1A1 (0.50) ALDH1A1LMNAPOLBGAAMAPT
SCHEMBL30204529 0.70 ALDH1A1 (0.50) ALDH1A1LMNAPOLBGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF RENQIU LIHE TECH LTD (CN) 2017-12-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF COG2, COG7, COG4 ALDH1A1 2496/4885LMNA 3701/4885POLB 632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback